Want to see CH:ADXN full AI Analyst Report?
Addex Therapeutics (ADXN) Income Statement
Addex Therapeutics Income Statement
Last quarter (Q2 2026), Addex Therapeutics's total revenue was $9.95K, a decrease of 66.53% from the same quarter last year. In Q2, Addex Therapeutics's net income was $-1.75M. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 173.00K | $ 410.04K | $ 1.61M | $ 1.42M | $ 2.92M | |
| $ 164.39K | $ -444.26K | $ -5.32M | $ -13.20M | $ -9.67M | |
| $ 2.99M | $ 2.31M | $ 2.67M | $ 3.76M | $ 5.84M | |
| Depreciation and Amortization | $ 8.47K | $ 260.12K | $ 305.95K | $ 323.14K | $ 347.61K |
| $ -2.81M | $ -4.65M | $ -10.26M | $ -20.43M | $ -14.94M | |
| $ -2.81M | $ -2.76M | $ -2.24M | $ -20.52M | $ -15.51M | |
| $ -4.03M | $ -2.15M | $ -257.19K | $ -284.01K | $ 154.00K | |
| $ -6.84M | $ -4.91M | $ -2.50M | $ -20.80M | $ -15.35M | |
| $ -6.73M | $ 7.06M | $ -10.56M | $ -20.80M | $ -15.41M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.06 | $ 0.07 | $ -0.14 | $ -0.46 | $ -0.45 |
| Diluted EPS | $ -0.06 | $ 0.07 | $ -0.14 | $ -0.46 | $ -0.45 |
| Weighted Average Shares Outstanding | 112.15M | 98.11M | 74.31M | 45.18M | 34.12M |
| Weighted Average Shares Outstanding (Diluted) | 112.15M | 98.34M | 74.31M | 45.18M | 34.12M |
Currency in CHF
